Environmental conditions are important for establishing and evaluating pre-clinical models of GVHD

Bone Marrow Transplantation

Volumn 47, Issue 4, 2012, Pages 607-609

  Christensen, M E ^a,b   Sinfield, L J ^a   Cullup, H ^a,b   Waterhouse, N J ^a,b   Atkinson, K ^a,b   Rice, A M ^a,b  

^a MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; CAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENVIRONMENTAL SANITATION; EXPERIMENTAL MOUSE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LETTER; MAJOR HISTOCOMPATIBILITY COMPLEX; MESENCHYMAL STROMA CELL; MOUSE; MYELOABLATIVE CONDITIONING; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; GRAFT VS HOST DISEASE; MICE; MICE, INBRED BALB C;

EID: 84859470692     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.128     Document Type: Letter

References (10)

1. Turner BE, Kambouris ME, Sinfield L, Lange J, Burns AM, Lourie R et al. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease. Transplantation 2008; 8: 968-976.
2. Jones TD, Snyder WS, Auxier JA. Absorbed dose, dose equivalent and LET distributions in cylindrical phantoms irradiated by a collimated beam of monoenergetic neutrons. Health Phys 1971; 21: 253-272.
3. van Bekkum DW, Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977; 58: 787-790. (Pubitemid 8056498)
4. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974; 52: 401-404.
5. Storb R, Prentice RL, Buckner CD, Clift RA, Appelbaum F, Deeg J et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983; 308: 302-307. (Pubitemid 13179412)
6. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood 1999; 93: 3267-3275. (Pubitemid 29220893)
7. Sudres M, Norol F, Trenado A, Gregoire S, Charlotte F, Levacher B et al. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006; 176: 7761-7767. (Pubitemid 43849077)
8. Markey KA, MacDonald KP, Hill GR. Recipient plasmacy-toid DCs are not required to prime allogeneic T-cell responses after BMT. Blood 2009; 113: 6038-6039.
9. Christensen ME, Turner BE, Sinfield LJ, Kollar K, Cullup H, Waterhouse NJ et al. Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease. Haematologica 2010; 95: 2102-2110.
10. Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371: 1579-1586. (Pubitemid 351626841)